• India Said to Seek Review of U.S. Court Ruling Papers on Ranbaxy
  • Swiss Billionaires Buy Merck Geneva Building for Biotech Campus
  • The Top Ten Stocks for Wednesday, May 22
  • Apple Got No Sweetheart Accord on Corporate Tax Bill, Irish Say
  • Glaxo to Get Up to $200 Million for U.S. Research
  • Kasowitz Benson, Eversheds, Latham: Business of Law
  • Google Joins Apple Avoiding Taxes With Stateless Income
  • Merck to Buy Back $5 Billion of Its Shares From Goldman
  • Deutsche Bank Seeks to Avoid Law Suits With Board Changes
  • Harvard’s Largest Gift Doubles With Second Wyss Donation
  • German Shares Climb 11th Day as Bullard Backs Bond Plan
  • Medtronic’s Heart Rhythm Devices Show Signs of Growth
  • Sanofi, Roll Global, Heineken, WWE: Intellectual Property
  • China Stocks Rise for Fifth Day, Longest Streak in Three Months
  • Novartis Sees MorphoSys Muscle-Atrophy Drug as Exciting
« Previous 1 2 3 4 5 Next »